You are here:

amlodipine besylate/valsartan (Exforge®)

Advice

Following an abbreviated submission

amlodipine/valsartan (Exforge) is accepted for use in NHS Scotland for patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.

In patients for whom concomitant use of these medicines as a fixed dose combination is appropriate it allows administration of a single tablet at no greater cost than valsartan (Diovan®) alone.

Angiotensin receptor blockers are an alternative to ACE inhibitors where these are not tolerated. This fixed dose combination is one of many options for the treatment of hypertension, many of which are less expensive.

Drug Details

Drug Name: amlodipine besylate/valsartan (Exforge®)
SMC Drug ID: 350/07
Manufacturer: Novartis Pharmaceuticals UK Ltd
Indication: For patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.
BNF Category:
Sub Category: 2.6 Nitrates*** calcium-channel blockers*** and other antianginal drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 12 March 2007

Back